Double Medical Technology Inc. (SHE:002901)
40.68
+0.10 (0.25%)
Nov 13, 2026, 3:04 PM CST
Double Medical Technology Revenue
Double Medical Technology had revenue of 736.56M CNY in the quarter ending September 30, 2026, with 10.62% growth. This brings the company's total for the last twelve months to 2.80B, up 12.83% year-over-year. In the year 2025, Double Medical Technology had annual revenue of 2.60B with 21.79% growth. That makes Double Medical Technology the 12,305th largest company in the world by revenue and 2,126th in China.
Revenue (ttm)
2.80B
Revenue Growth
+12.83%
P/S Ratio
5.85
Revenue / Employee
595.46K
Employees
4,704
Market Cap
16.38B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Double Medical Technology breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.60B | 465.30M | 21.79% |
| Dec 31, 2024 | 2.14B | 602.44M | 39.29% |
| Dec 31, 2023 | 1.53B | 99.02M | 6.90% |
| Dec 31, 2022 | 1.43B | -560.23M | -28.09% |
| Jan 1, 2022 | 1.99B | 407.47M | 25.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Yuyue Medical Equipment & Supply | 8.02B |
| Lepu Medical Technology (Beijing) | 6.17B |
| Shandong Weigao Blood Purification Products | 5.40B |
| Autobio Diagnostics | 4.34B |
| Cofoe Medical Technology | 4.18B |
| MGI Tech | 3.01B |
| Qingdao Haier Biomedical Co.,Ltd | 2.53B |
| Jafron Biomedical | 2.07B |